Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral stem cell transplantation

✍ Scribed by Tsai, D E; Moore, H C F; Hardy, C L; Porter, D L; Loh, E Y; Vaughn, D J; Luger, S; Schuster, S J; Stadtmauer, E A

• Book ID: 110012182
• Publisher: Nature Publishing Group
• Year: 1999
• Tongue: English
• Weight: 52 KB
• Volume: 24
• Category: Article
• ISSN: 0007-1188
• DOI: 10.1038/sj.bmt.1701944